These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 375453)
21. [Comparative evaluation of the effect of intestopane and colibacterin on the intestinal microbial flora in chronic enterocolitis]. Zlatkina AR; Misautova AA; Makievskaia SE; Paleĭ OS Ter Arkh; 1976; 48(12):70-5. PubMed ID: 797032 [No Abstract] [Full Text] [Related]
22. [The efficacy of bifidum-containing preparations in enterogenous reactive arthritis]. Rubtsov OV; Bevz NI; Agababova ER; Goncharova GI Ter Arkh; 1991; 63(5):33-6. PubMed ID: 1887411 [TBL] [Abstract][Full Text] [Related]
23. [Intestinal dysbacteriosis in yersiniosis patients and the possibility of its correction with biopreparations]. Kuznetsov VF; Iushchuk ND; Iurko LP; Nabokova NIu Ter Arkh; 1994; 66(11):17-8. PubMed ID: 7900004 [TBL] [Abstract][Full Text] [Related]
24. [A new therapy against the endogenous factor of periodontosis]. Ebner N Osterr Z Stomatol; 1972 Jan; 69(1):24-9. PubMed ID: 4623170 [No Abstract] [Full Text] [Related]
25. [Dysbiosis-treatment]. Recktenwald M Z Allgemeinmed; 1973 Jul; 49(20):980. PubMed ID: 4200157 [No Abstract] [Full Text] [Related]
26. [The microbiocenosis of the intestines and its influence on the course of postenterocolitic reactive arthritis]. Rubtsov OV; Bevz NI; Agababova ER; Goncharova GI Revmatologiia (Mosk); 1990; (2):46-50. PubMed ID: 2218264 [TBL] [Abstract][Full Text] [Related]
27. [Endogenic infectious diseases and and prospects of their treatment]. Bilibin AF; Markova EA; Dvurechenskaia GS Ter Arkh; 1975; 47(8):9-18. PubMed ID: 1188658 [No Abstract] [Full Text] [Related]
28. [Comparative efficacy of different methods in treatment of patients with acute dysentery]. Gebesh VV; Ianushevskaia RI; Babak VI; Kirienko MS; Lysak LI Vrach Delo; 1977 May; (5):137-41. PubMed ID: 141789 [No Abstract] [Full Text] [Related]
29. [Use of milk colibacterin to reduce intestinal dysbacteriosis in children]. Krivogorskiĭ EB; Malkina RD; Mikitina RV Pediatriia; 1970 May; 49(5):58-61. PubMed ID: 4915113 [No Abstract] [Full Text] [Related]
30. [Use of bacteriophages in complex treatment of proctological patients]. Fedorov VD; Marko OP; Bronshteĭn AS; Kamaeva DK; Turovtseva VV Klin Med (Mosk); 1976 Apr; 54(4):127-32. PubMed ID: 138022 [No Abstract] [Full Text] [Related]
31. [Effect of fungal dysbacteriosis on the treatment of children with acute dysentery]. Moshchich PS; Belousova NV; Dishchuk II; Mrinskaia NI Pediatriia; 1979 Feb; (2):43-5. PubMed ID: 450581 [No Abstract] [Full Text] [Related]
32. [Clinical manifestations and treatment of intestinal dysbacteriosis in patients with Flexner's dysentery]. Shakhmardanov MZ; Luchshev VI; Bondarenko VM; Isaeva NN Klin Med (Mosk); 1997; 75(7):47-9. PubMed ID: 9411056 [TBL] [Abstract][Full Text] [Related]
33. [Changes in the intestinal microflora in dysenteric patients depending on the method of administration of tetracycline]. Klimov KV Antibiotiki; 1966 Nov; 11(11):1050-4. PubMed ID: 4968144 [No Abstract] [Full Text] [Related]
34. [Use of bificol for treating adults with postdysenteric colitis]. Suzdal'tsev AA Vrach Delo; 1980 Jul; (7):115-7. PubMed ID: 6998122 [No Abstract] [Full Text] [Related]
35. [Pathogenesis, clinical aspects and treatment of chronic colitis]. Levitan MKh; Dubinin AV; Dement'eva OP; Zhukov AV Sov Med; 1979 May; (5):30-6. PubMed ID: 451720 [No Abstract] [Full Text] [Related]
36. [Effectiveness of bacterial preparations bifidumbacterin and bificol in the treatment of chronic enterocolitis complicated by dysbacteriosis]. Krums LM; Zhukovskaia NA; Semenova LP; Goncharova GI; Pospelova VV Ter Arkh; 1975; 47(8):86-9. PubMed ID: 1188656 [No Abstract] [Full Text] [Related]
37. [Use of bifidumbacterin for the correction of intestinal dysbacteriosis]. Liz'ko NN; Goncharova GI Kosm Biol Aviakosm Med; 1987; 21(4):70-2. PubMed ID: 3657069 [No Abstract] [Full Text] [Related]
38. [Treatment of intestinal dysbiosis with Hylakombun]. Cohrs GW Munch Med Wochenschr; 1972 Feb; 114(5):196-200. PubMed ID: 4622014 [No Abstract] [Full Text] [Related]
39. [Clinical and bacteriologic results of administering lactic enzymes. Their role in the prevention of digestive disorders in antibiotic therapy]. Leperchey E; Frottier J Sem Ther; 1965 Apr; 41(4):221-7. PubMed ID: 5878915 [No Abstract] [Full Text] [Related]
40. [Use of colibacterin in a tablet form in post-dysenteric intestinal lesions]. Marko OP; Bronshteĭn AS; Lialiaeva NA Sov Med; 1976; (5):67-71. PubMed ID: 788183 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]